NewAmsterdam, Menarini Receive CHMP Recommendation for Ubeslo and Evlarco
NewAmsterdam and Menarini received a positive CHMP opinion patent dosing options for obicetrapib, pending further regulatory review.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day